LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 567 | 3933 | 0.1442 | -0.0560 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 574 | 3761 | 0.1529 | -0.0538 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 556 | 3933 | 0.1414 | -0.0638 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 540 | 3761 | 0.1437 | -0.0755 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 72 | hr | 658 | 608 | 3933 | 0.1547 | -0.0325 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 72 | hr | 658 | 436 | 3761 | 0.1159 | -0.1512 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 658 | 779 | 3933 | 0.1981 | 0.0675 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 658 | 764 | 3933 | 0.1943 | 0.0592 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 658 | 789 | 3933 | 0.2006 | 0.0727 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 658 | 716 | 3933 | 0.1820 | 0.0327 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 658 | 791 | 3933 | 0.2012 | 0.0734 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 72 | hr | 658 | 786 | 3933 | 0.1998 | 0.0712 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3808 | 3761 | 1.0127 | 1.0099 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3710 | 3761 | 0.9865 | 0.9892 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 658 | 3634 | 3761 | 0.9665 | 0.9729 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3672 | 3761 | 0.9764 | 0.9811 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3729 | 3761 | 0.9915 | 0.9930 |
Hs 578T | Imatinib | 10 | uM | LJP6 | 72 | hr | 658 | 3447 | 3761 | 0.9161 | 0.9310 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3080 | 3761 | 0.8188 | 0.8470 |
Hs 578T | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 658 | 2583 | 3761 | 0.6867 | 0.7222 |
Hs 578T | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 658 | 1913 | 3761 | 0.5085 | 0.5282 |
Hs 578T | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 658 | 1122 | 3761 | 0.2987 | 0.2319 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 658 | 832 | 3761 | 0.2213 | 0.0978 |
Hs 578T | NVP-TAE684 | 10 | uM | LJP6 | 72 | hr | 658 | 210 | 3761 | 0.0561 | -0.3648 |
Hs 578T | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 658 | 2861 | 3933 | 0.7273 | 0.7675 |